Emma Fatzaun King
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Emma Fatzaun King has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Annette M. Jackson
Department of Surgery, Duke University, Durham, North Carolina, USA
2 shared publications - Ashley Drabik
Duke Transplant Center, Duke University School of Medicine, Durham, NC 27710, USA
2 shared publications - Jean Kwun
Duke Transplant Center, Duke University School of Medicine, Durham, NC 27710, USA
2 shared publications - Shengli Song
Duke University
2 shared publications - Stuart J. Knechtle
Duke Transplant Center, Department of Surgery, Duke University Medical Center, Durham, NC 27710
2 shared publications - Alessandro Martinino
Department of Surgery, Duke University, Durham, USA
1 shared publication
Latest Publications
- Open Access
Profiling Allogeneic HLA-specific B-cell Responses Utilizing a 64-plex Single-HLA Reporter Cell Panel
Identifying allogeneic HLA-specific B cells in sensitized individuals is essential for defining the cellular basis of allogeneic humoral immunity but remains technically challenging due to their low frequency. To overcome this barrier, we generated a 64-plex single-HLA reporter cell (HLA64-RC) panel that provides a cost-efficient, multiplex, high-throughput platform for screening B-cell specificity. We additionally developed a companion R package, HLA64 , for automated data analysis and visualization. Integrated with a streamlined high-throughput BCR discovery workflow, this platform enables reliable identification and characterization of allogeneic HLA-specific B cells from sensitized transplant candidates. In a pilot application, thirteen HLA-specific B cells were identified, enabling linked analyses of phenotype, function, and BCR genetics. These B cells exhibited an IgG + CD24 low phenotype, diverse HLA allele-specificity profiles, and recurrent heavy- and light-chain V-gene usage. In two independent B-cell lineages, clonal members within each lineage displayed divergent binding patterns despite sharing a common clonal origin. Broader application of this approach for systematic profiling of alloreactive B-cell responses will help elucidate the molecular basis of allorecognition, define immunodominant HLA eplets, and ultimately improve immunological risk assessment and allograft outcomes in transplant recipients.
Open AccessProfiling Allogeneic HLA-specific B-cell Responses Utilizing a 64-plex Single-HLA Reporter Cell Panel
Identifying allogeneic HLA-specific B cells in sensitized individuals is essential for defining the cellular basis of allogeneic humoral immunity but remains technically challenging due to their low frequency. To overcome this barrier, we generated a 64-plex single-HLA reporter cell (HLA64-RC) panel that provides a cost-efficient, multiplex, high-throughput platform for screening B-cell specificity. We additionally developed a companion R package, HLA64 , for automated data analysis and visualization. Integrated with a streamlined high-throughput BCR discovery workflow, this platform enables reliable identification and characterization of allogeneic HLA-specific B cells from sensitized transplant candidates. In a pilot application, thirteen HLA-specific B cells were identified, enabling linked analyses of phenotype, function, and BCR genetics. These B cells exhibited an IgG + CD24 low phenotype, diverse HLA allele-specificity profiles, and recurrent heavy- and light-chain V-gene usage. In two independent B-cell lineages, clonal members within each lineage displayed divergent binding patterns despite sharing a common clonal origin. Broader application of this approach for systematic profiling of alloreactive B-cell responses will help elucidate the molecular basis of allorecognition, define immunodominant HLA eplets, and ultimately improve immunological risk assessment and allograft outcomes in transplant recipients.
- 23 October 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (6) , 1363-1375
A novel immunoglobulin G- and immunoglobulin cleaving enzyme MG (IceMG), for antibody-mediated rejection
- 23 October 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (6) , 1363-1375
A novel immunoglobulin G- and immunoglobulin cleaving enzyme MG (IceMG), for antibody-mediated rejection